Carroll Hospital Group Inc. – Trademark Portfolio
Entity Type: 03
Carroll Hospital Group Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 9 filings in this category. The portfolio also extends into Class 6 (Metal Goods) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include CHG, SPIRIT PLUS, SPIRIT SELECT, and CHG HOSPITAL BEDS. The owner is based in London, Ontario.
153 Towerline Place
London, Ontario N6E2T3 , CA
Showing of trademarks Trademarks
Trademark Classifications
Carroll Hospital Group Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Common metals and their alloys; metal building materials; transportable buildings of metal
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Carroll Hospital Group Inc. have?
Carroll Hospital Group Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned, 2 cancelled.
What trademark classes does Carroll Hospital Group Inc. file in?
Carroll Hospital Group Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 6 (Metal Goods), Class 16 (Paper Goods). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.
What are Carroll Hospital Group Inc.'s most well-known trademarks?
Carroll Hospital Group Inc.'s registered trademark portfolio includes well-known marks such as CHG, SPIRIT PLUS, SPIRIT SELECT, and CHG HOSPITAL BEDS. These are among 5 currently registered trademarks in the portfolio.
What is Carroll Hospital Group Inc.'s trademark registration success rate?
Carroll Hospital Group Inc. has a 50% trademark registration rate, with 5 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.